Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01
Open accessThe DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Abstract
An oncolytic adenovirus shows antitumor efficacy in patient-derived models of intraocular retinoblastoma and appears safe for human use.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Despite these advances, adenovirus vectors are typically not used for retinal gene therapy and targeting retinoblastoma with oncolytic adenovirus VCN-01is the only Ad vectored clinical trial in the ocular field.62,63”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [63]
Citations
Cites
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.72351 · Cited by 6,277
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Oncolytic viruses: a new class of immunotherapy drugs
Kaufman, H. L., Kohlhapp, F. J., & Zloza, A. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4663 · Cited by 1,642
Sibling rivalry in the E2F family
Trimarchi, J. M., & Lees, J. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm714 · Cited by 1,158 · cited 1×
“E2Fs are a broad family of transcription factors with conserved DNA binding domains that bind target promoters controlling the expression of key cell cycle regulators (16, 17).”
BackgroundEmerging roles of E2Fs in cancer: an exit from cell cycle control
Chen, H.-Z., Tsai, S.-Y., & Leone, G. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2696 · Cited by 1,021
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
Fueyo, J., Gomez-Manzano, C., Alemany, R., Lee, P. S., McDonnell, T. J., Mitlianga, P., Shi, Y.-X., Levin, V. A., Yung, W. K. A., & Kyritsis, A. P. (2000) · Oncogene · doi:10.1038/sj.onc.1203251 · Cited by 764
Self-citationPharmacokinetic aspects of retinal drug delivery
del Amo, E. M., Rimpelä, A.-K., Heikkinen, E., Kari, O. K., Ramsay, E., Lajunen, T., Schmitt, M., Pelkonen, L., Bhattacharya, M., Richardson, D., et al. (2017) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2016.12.001 · Cited by 693
Intraocular Retinoblastoma: the Case for a New Group Classification
LINNMURPHREE, A. (2005) · Ophthalmology Clinics of North America · doi:10.1016/j.ohc.2004.11.003 · Cited by 683
Research works printed but not linked: 1
- 10.1002/(SICI)1098-1004(199910)14:4<283::AID-HUMU2>3.0.CO;2-J · DOI · Paper page
Cited by
Exploring treatment options in cancer: tumor treatment strategies
Liu, B., Zhou, H., Tan, L., Siu, K. T. H., & Guan, X.-Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01856-7 · Cited by 1,201
Cancer vaccines: the next immunotherapy frontier
Lin, M. J., Svensson-Arvelund, J., Lubitz, G. S., Marabelle, A., Melero, I., Brown, B. D., & Brody, J. D. (2022) · Nature Cancer · doi:10.1038/s43018-022-00418-6 · Cited by 843
Recent advances of oncolytic virus in cancer therapy
Mondal, M., Guo, J., He, P., & Zhou, D. (2020) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1723363 · Cited by 224
Munier, F. L., Beck-Popovic, M., Chantada, G. L., Cobrinik, D., Kivelä, T. T., Lohmann, D., Maeder, P., Moll, A. C., Carcaboso, A. M., Moulin, A., et al. (2019) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2019.05.005 · Cited by 215
Self-citationDelivery and Biosafety of Oncolytic Virotherapy
Li, L., Liu, S., Han, D., Tang, B., & Ma, J. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00475 · Cited by 159
Metadata
- Authors
- Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., Cuadrado-Vilanova, M., Castillo-Ecija, H., Botteri, G., Garcia-Gerique, L., Moreno-Gilabert, H., Gimenez-Alejandre, M., Alonso-Lopez, P., Farrera-Sal, M., Torres-Manjon, S., Ramos-Lozano, D., Moreno, R., Aerts, I., Doz, F., Cassoux, N., Chapeaublanc, E., Torrebadell, M., Roldan, M., König, A., Suñol, M., Claverol, J., Lavarino, C., Carmen de, T., Fu, L., Radvanyi, F., Munier, F. L., Catalá-Mora, J., Mora, J., Alemany, R., Cascalló, M., Chantada, G. L., & Carcaboso, A. M.
- Affiliations
- Institut de Recerca Sant Joan de Deu, Barcelona 08950, Spain.
- VCN Biosciences, Sant Cugat del Valles, Barcelona 08174, Spain.
- Hospital Sant Joan de Déu Barcelona (ES)
- Pathology, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
- Centre National de la Recherche Scientifique (FR)
- Chronobiotron (FR)
- Institut d'Investigació Biomédica de Bellvitge (ES)
- Vivotecnia Research S.L., Tres Cantos, Madrid 28760, Spain.
- Pediatric Hematology-Oncology, Hospital Escuela Universitario, Tegucigalpa, Honduras.
- Hôpital Ophtalmique Jules-Gonin (CH)
- Ophthalmology, Hospital Sant Joan de Deu, Barcelona 08950, Spain.
- Corresponding author
- Carcaboso, Angel M.
- ORCID
- Pascual-Pasto, Guillem
- Bazan-Peregrino, Miriam
- Mato-Berciano, Ana
- Ottaviani, Daniela
- Weber, Klaus
- Paco, Sonia
- Castillo-Ecija, Helena
- Botteri, Gaia
- Garcia-Gerique, Laura
- Moreno-Gilabert, Helena
- Farrera-Sal, Marti
- Torres-Manjon, Silvia
- Moreno, Rafael
- Aerts, Isabelle
- Doz, François
- Cassoux, Nathalie
- Chapeaublanc, Elodie
- Torrebadell, Montserrat
- Suñol, Mariona
- Claverol, Joana
- Lavarino, Cinzia
- Radvanyi, François
- Munier, Francis L.
- Catalá-Mora, Jaume
- Alemany, Ramón
- Cascalló, Manel
- Chantada, Guillermo L.
- Carcaboso, Angel M.
- Venue
- Science Translational Medicine
- Published
- 2019-01-23
- Volume
- 11
- Issue
- 476
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2911889173
- Cited by
- 118
- References
- 57
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 23 · 2023: 15 · 2022: 17 · 2021: 15 · 2020: 14 · 2019: 7
- FWCI
- 7.99
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- cc-by-nc-sa
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- IRIS (submittedVersion)
- Conicet (submittedVersion, cc-by-nc-sa)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- Seventh Framework Programme (PIRG-08-GA-2010-276998)
- Institut national de la santé et de la recherche médicale (Cancer plan)
- Fundación Científica Asociación Española Contra el Cáncer (Ayuda Retorno Investigadores)
- Instituto de Salud Carlos III (CP13/00189)
- Institut National Du Cancer
- Ministerio de Economía, Industria y Competitividad, Gobierno de España (Cure4RB project RTC-2015-4319-1)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- retinoblastoma, oncolytic adenovirus, E2F1, brain metastasis prevention, chemoresistance, vitreous inflammation, ocular survival
- MeSH terms
- Adenoviridae, Animals, Cytotoxicity, Immunologic, Humans, Neoplasm Metastasis, Rabbits, Retinoblastoma, Tissue Distribution, Virus Replication, Signal Transduction, Survival Analysis, Retinoblastoma Protein, Treatment Outcome, Xenograft Model Antitumor Assays, Cell Line, Tumor, Oncolytic Viruses, Mice, Translational Research, Biomedical, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. https://app.cochat.ai/papers/10.1126/scitranslmed.aat9321
- The paper
- Pascual-Pasto, G., Bazan-Peregrino, M., Olaciregui, N. G., Restrepo-Perdomo, C. A., Mato-Berciano, A., Ottaviani, D., Weber, K., Correa, G., Paco, S., Vila-Ubach, M., Cuadrado-Vilanova, M., Castillo-Ecija, H., Botteri, G., Garcia-Gerique, L., Moreno-Gilabert, H., Gimenez-Alejandre, M., Alonso-Lopez, P., Farrera-Sal, M., Torres-Manjon, S., . . . Carcaboso, A. M. (2019). Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aat9321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.